Delivered as Hybrid Event from 15-19 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, BelgiumWendy Broom, PhDDirector of Oncology at Codiak Biosciences
Profile
Wendy Broom currently directs the Oncology group at Codiak BioSciences, driving multiple programs through pre-clinical to clinical phase development utilizing their engX™ Platform. She is focused on the development of exosome based therapeutics for oncology and immune-oncology indications.
Agenda Sessions
Delivery of Antisense Oligonucleotide-loaded Exosome to Target Macrophage Reprogramming, Reduce the Immunosuppressive Tumor Microenvironment and Generate Potent Anti-tumor Efficacy
On DemandView SessionDiscovery, Preclinical and Clinical Development of Oligonucleotides
12:15View Session